August 5, 2020 Comments Off on Investor Alert: Matinas BioPharma Holdings Inc.  Blog, Current Investigations

Investor Alert: Matinas BioPharma Holdings Inc. 

Investor Alert: Matinas BioPharma Holdings Inc. , featured by top securities fraud attorneys, The White Law Group

Matinas BioPharma Holdings Inc. – Investigating Potential Claims

Are you concerned about your investment losses in Matinas BioPharma Holdings Inc.? If so, the securities attorneys at The White Law Group may be able to help you by filing a FINRA Dispute Resolution claim against the brokerage firm that sold you the investment.

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company based in Bedminster, NJ. 

The company filed a Form D to raise capital from investors in 2017, according to filings with the SEC. The total offering amount sold was purportedly $15,483,175. 

In January the company announced that it commenced an underwritten public offering of its common stock. Unfortunately for investors, according to Market Watch, Matinas BioPharma Holdings shares are down -62.50% YTD.

Filing a Complaint against your Brokerage Firm

The White Law Group is investigating the liability that FINRA registered brokerage firms may have for improperly recommending high-risk investments to investors.

The problem with medical technology investments such as Matinas BioPharma Holdings Inc. is that they typically involve a high degree of risk. The research and development process for tech companies often involves costly and lengthy clinical testing trials that yield specific data. If the expected data or end points are not met, that could be bad news for investors.

Without a strong understanding of the company and its basic operations, investors may be looking at serious losses.

Broker dealers are required to perform adequate due diligence on any investment they recommend and to ensure that all recommendations are suitable for the investor. Firms that fail to do so, may be held responsible for any losses in a FINRA arbitration claim.

If you have concerns regarding investment losses in Matinas BioPharma Holdings Inc. please call the securities attorneys at The White Law Group for a free consultation at 888-637-5510.

The White Law Group, LLC is a national securities fraud, securities arbitration, investor protection, and securities regulation/compliance law firm with offices in Chicago, Illinois and Franklin, Tennessee.

For more information on The White Law Group and its representation of investors in FINRA arbitration claims, visit https://www.whitesecuritieslaw.com.

 

 

 

Comments are closed.